We are live on
!
Find out more
SGAM
Smith Group Asset Management Portfolio holdings
AUM
$2.46B
1-Year Est. Return
57.16%
This Fund
S&P 500
This Quarter
Est. Return
+31.89%
1 Year Est. Return
+57.16%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.81B
AUM Growth
-$18.2M
(-0.99%)
Cap. Flow
-$444M
Cap. Flow
% of AUM
-24.46%
Top 10 Holdings %
Top 10 Hldgs %
40.04%
Holding
396
New
38
Increased
53
Reduced
183
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HOLX
Hologic
HOLX
|
+$24.1M |
| 2 |
Parker-Hannifin
PH
|
+$20.9M |
| 3 |
Ameriprise Financial
AMP
|
+$15.8M |
| 4 |
THS
Treehouse Foods
THS
|
+$12.2M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$12.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$48.5M |
| 2 |
Microsoft
MSFT
|
+$45.5M |
| 3 |
Biogen
BIIB
|
+$36M |
| 4 |
Amazon
AMZN
|
+$29.7M |
| 5 |
Burlington
BURL
|
+$25.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.49% |
| 2 | Healthcare | 16.85% |
| 3 | Consumer Discretionary | 12.94% |
| 4 | Communication Services | 8.43% |
| 5 | Industrials | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Deluxe
DLX
$1.12B
| $300K | 0.02% |
12,733
-44
| -0.3% | -$1.1K |
|
152
Dine Brands
DIN
$453M
| $293K | 0.02% |
6,963
-25
| -0.4% | -$1.01K |
|
|
BDSI
153
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $276K | 0.02% |
63,239
-780
| -1% | -$3.5K |
|
154
The RMR Group
RMR
$335M
| $265K | 0.01% |
9,000
-130
| -1% | -$3.76K |
|
155
Diodes
DIOD
$4.65B
| $264K | 0.01% |
5,198
-80
| -2% | -$3.83K |
|
|
GMS
156
DELISTED
GMS Inc
GMS
| $253K | 0.01% |
10,271
-130
| -1% | -$2.48K |
|
157
Green Dot
GDOT
$752M
| $239K | 0.01% |
+4,860
| New | +$164K |
|
158
Kforce
KFRC
$1.04B
| $236K | 0.01% |
8,080
-110
| -1% | -$3.2K |
|
|
HZNP
159
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $230K | 0.01% |
4,140
-70
| -2% | -$3K |
|
160
Artisan Partners
APAM
$3B
| $215K | 0.01% |
6,630
-90
| -1% | -$2.5K |
|
|
MANT
161
DELISTED
Mantech International Corp
MANT
| $212K | 0.01% |
+3,100
| New | +$228K |
|
|
MGLN
162
DELISTED
Magellan Health Services, Inc.
MGLN
| $212K | 0.01% |
2,900
-3,400
| -54% | -$218K |
|
163
Personalis
PSNL
$1.55B
| $205K | 0.01% |
15,830
-200
| -1% | -$2.22K |
|
164
Federated Hermes
FHI
$4.71B
| $204K | 0.01% |
8,590
+6,180
| +256% | +$137K |
|
|
MEET
165
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $201K | 0.01% |
32,138
-380
| -1% | -$2.34K |
|
166
Newmark Group
NMRK
$2.52B
| $199K | 0.01% |
40,960
-590
| -1% | -$2.48K |
|
|
IMMU
167
DELISTED
Immunomedics Inc
IMMU
| $194K | 0.01% |
5,480
-80
| -1% | -$2.34K |
|
168
Acadia Pharmaceuticals
ACAD
$5.06B
| $180K | 0.01% |
3,720
-60
| -2% | -$2.88K |
|
169
HealthStream
HSTM
$859M
| $177K | 0.01% |
7,980
-90
| -1% | -$2.08K |
|
170
Curtiss-Wright
CW
$25.6B
| $176K | 0.01% |
1,970
-40
| -2% | -$3.81K |
|
|
SNBR
171
DELISTED
Sleep Number
SNBR
| $172K | 0.01% |
4,130
-50
| -1% | -$1.59K |
|
172
Repligen
RGEN
$9.21B
| $171K | 0.01% |
1,380
-10
| -0.7% | -$1.18K |
|
173
Ultragenyx Pharmaceutical
RARE
$2.64B
| $154K | 0.01% |
1,970
-30
| -2% | -$1.99K |
|
174
Commault Systems
CVLT
$5.78B
| $152K | 0.01% |
3,930
-12,937
| -77% | -$513K |
|
175
EXL Service
EXLS
$5.32B
| $151K | 0.01% |
11,900
-150
| -1% | -$1.77K |
|
Similar funds
M
GWM
QT
SCM
TW
KFA
SG
FFA
Smith Group Asset Management's Q2 2020 Portfolio in Review
As of Q2 2020, Smith Group Asset Management held 396 positions worth $1.81B, down 0.99% from $1.83B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Smith Group Asset Management withdrew a net $444M in Q2 2020, closing 98 positions and reducing 183 holdings. Its most notable exit was Biogen, an estimated $36M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 37% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Smith Group Asset Management opened a new position in Hologic worth $28M.
- Smith Group Asset Management's largest Q2 2020 buy was Hologic: 490,762 shares worth $28M.
- Smith Group Asset Management added most to Ameriprise Financial in Q2 2020, an estimated $15.8M increase.
- Smith Group Asset Management's biggest Q2 2020 reduction was Apple, cutting an estimated $48.5M.
- Smith Group Asset Management fully exited Biogen in Q2 2020, selling an estimated $36M.
- Smith Group Asset Management's ten largest holdings make up 40% of its $1.81B portfolio in Q2 2020.
- Smith Group Asset Management opened 38 new positions and closed 98 in Q2 2020.
- Smith Group Asset Management's portfolio value fell 0.99% quarter-over-quarter to $1.81B.
Based on Smith Group Asset Management's 13F filing for Q2 2020, filed 6 Aug 2020.